本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Altimmune, Inc.

3.23
-0.0700-2.12%
盤後3.240.0100+0.31%16:20 EDT
成交量:233.24萬
成交額:758.92萬
市值:6.27億
市盈率:-4.25
高:3.31
開:3.30
低:3.21
收:3.30
52周最高:6.44
52周最低:2.56
股本:1.94億
流通股本:1.64億
量比:0.81
換手率:1.42%
股息:- -
股息率:- -
每股收益(TTM):-0.7600
每股收益(LYR):-0.9999
淨資產收益率:-28.87%
總資產收益率:-17.20%
市淨率:1.32
市盈率(LYR):-3.23

資料載入中...

2024/12/11

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/17

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/16

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/26

重要事件披露

Form 8-K - Current report
2024/08/15

重要事件披露

Form 8-K - Current report
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/26

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/03/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]